Draghia-Akli Ruxandra bought NVAX
November 11, 2024 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 42,770 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,770
Price
$0.00
Total value
N/A
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateNovember 11, 2024
Filing dateNovember 13, 2024
Shares owned after42,770
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.; One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.